Genetic manipulation studies indicate that upregulation of ARTN increases the resistance of mammary carcinoma cells to trastuzumab; silencing of ARTN enhanced the efficacy of trastuzumab.90 The gene discussed is ARTN; the disease is breast carcinoma.